PT - JOURNAL ARTICLE AU - Saito, Takesi AU - Shigemoto, Kazuyasu TI - A Logistic Curve in the SEIR Model and the Basic Reproduction Number of COVID-19 in Japan AID - 10.1101/2022.09.18.22279896 DP - 2022 Jan 01 TA - medRxiv PG - 2022.09.18.22279896 4099 - http://medrxiv.org/content/early/2022/09/26/2022.09.18.22279896.short 4100 - http://medrxiv.org/content/early/2022/09/26/2022.09.18.22279896.full AB - The SEIR model is one of modified models of SIR, especially taken into account of exposed people. SEIR equations can be solved numerically, but it is hard to obtain analytically. Here, we propose some approximate solutions of SEIR equations, one of which is related with the logistic formula in Biology. As the second aim, the SEIR model is applied to the 7th-wave of COVID-19 in Japan. The basic reproduction number (α) in the SEIR model is estimated for the Omicron wave. We make use of data of the removed number R(t) rather than that of the infective number, because the latter seems to be ambiguous. This analysis gives α = 10 with γ = 1 and σ = 0.5.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced are available online at Yahoo Japan News page "Summary of the New Coronavirus Infection"(in Japanese), https://news.yahoo.co.jp/pages/article/20200207 and Toyokeizai net page "Status of the Domestic New Coronavirus Infection"(in Japanese), https://toyokeizai.net/sp/visual/tko/covid19/ https://news.yahoo.co.jp/pages/article/20200207 https://toyokeizai.net/sp/visual/tko/covid19/